FDA Investigator Raquel Gonzalez
Raquel Gonzalez has inspections in 3 countries as of 03 Aug 2023. Raquel Gonzalez has collaborated with a combined 1409 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
03 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
China,
Austria,
United States of America
Co-Investigator(s):
Anastasia G Lolas,
Ariel Cruz Figueroa,
Arlene M Badillo,
Brenda Rivera,
Burnell M Henry,
Carolyn A Renshaw,
Christopher T Middendorf,
Concepcion Cruz, Jr,
Cynthia Jim, CSO,
Dennis Cantellops Paite,
Diane L Raccasi,
Dr. Ralph M Bernstein, PhD,
Edwin Martinez,
German Rivera,
Iraida Ortiz,
Ivis Lnegron Torres,
Jacqueline Mdiaz Albertini,
Joan Cantellops,
Joan M Cantellops Figueroa,
Jorge L Guadalupe,
Jose A Moreno,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose E Melendez, DDC,
Jose Lpez,
Jose Velez,
Joseph A Piechocki,
Justin A Boyd,
Kevin A Gonzalez,
Kham Phommachanh,
Krishna Ghosh, PhD,
Lareese K Thomas,
Laura E Garcia,
Laurimer Kuilan Torres,
Libia M Lugo,
Linda N Thai,
Linda Thai,
Lisa M Lopez,
Maria Cecilia Tami, PhD,
Maria Joselopez Barragan, PhD,
Marian E Ramirez,
Marianela Aponte Cruz,
Mary E Farbman, PhD,
Miguel A Martinez,
Miguel Hernandez Sanchez,
Milva E Melendez,
Mra Mcculloughj,
Myriam M Sosa,
Noreen Muniz,
Omotunde O Osunsanmi,
Pablo Feliciano,
Patrick C Klotzbuecher,
Peter E Baker,
Prabhu P Raju,
Ram Sihag, PhD,
Ramon A Hernandez,
Rapti D Madurawe,
Raquel Gonzalez Rivera,
Rebeca M Melendez,
Rebecca Parrilla,
Rebecca Rodriguez,
Richard Ledwidge (nmi), PhD,
Rose M Ashley,
Rumany C Penn, PharmD,
Sang Bong Lee,
Santos E Camara,
Steven Fong, MS, PhD,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Vilmary Negron Rodriguez,
Vincent Thomas,
Viviana Matta,
Ying Zhang,
Zhihao Qiu (Peter), PhD
Raquel Gonzalez's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2019 | FDA 483 | Zhuhai United Laboratories Co., Ltd - Form 483, 2019-07-16 |
July, 2017 | FDA 483 | Lilly del Caribe, Inc. - Form 483, 2017-07-21 |
June, 2016 | FDA 483 | Pharma-Bio Serv, Inc - Form 483, 2016-07-01 |
March, 2017 | FDA 483 | Boehringer Ingelheim RCV GmbH & Co KG - Form 483, 2017-03-17 |
July, 2016 | FDA 483 | AbbVie Ltd - Form 483, 2016-07-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more